TBTaqwa Brookins

Taqwa Brookins

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Taqwa Brookins has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Bow Suprasert

    Center for Public Health Research, San Francisco Department of Public Health, San Francisco, USA

    1 shared publication
  • Danyion Reagan

    San Francisco Department of Public Health, Center for Public Health Research, San Francisco, USA

    1 shared publication
  • Erin C. Wilson

    Center for Public Health Research, San Francisco Department of Public Health, San Francisco, USA

    1 shared publication
  • Kassandra Miller

    San Francisco Department of Public Health, Center for Public Health Research, San Francisco, USA

    1 shared publication
  • Kelly D. Taylor

    Affiliations Institute for Global Health Sciences, University of California (UCSF), San Francisco, California, United States of America, Division of Prevention Sciences, Department of Medicine, UCSF, San Francisco, California, United States of America

    1 shared publication
  • Moranda Tate

    San Francisco Department of Public Health, Center for Public Health Research, San Francisco, USA

    1 shared publication

Latest Publications

  • Disparities in HIV Testing and PrEP Awareness for Black Women who Inject Drugs in San Francisco, California

    by Taqwa Brookins, Danyion Reagan, Moranda Tate, Bow Suprasert, Kelly D. Taylor, Raul Ruiz, Kassandra Miller, Erin C. Wilson, Willi McFarland

    HIV disproportionately affects Black/African Americans (AA), while PrEP is under-utilized by Black/AA, women, and people who inject drugs (PWID). In San Francisco, California’s National HIV Behavioral Surveillance among PWID in 2022, Black/AA women were the least likely to be tested for HIV among all groups by sex and race/ethnicity and the least likely to be aware of PrEP among women. Yet, Black/AA women were no less likely to see a healthcare provider in the last year. Data suggest that providers’ failure to discuss and address HIV risk with Black/AA female PWID is a major barrier to accessing effective care and prevention. El VIH afecta de manera desproporcionada a Black/afroamericanos (AA), mientras que la PrEP está infrautilizada por los Black/AA, las mujeres y las personas que se inyectan drogas (PWID). En la National HIV Behavioral Surveillance de PWID de San Francisco, California en 2022, las mujeres Black/AA eran las que menos probabilidades tenían de someterse a la prueba del VIH entre todos los grupos por sexo y raza/etnia y las que menos probabilidades tenían de conocer la PrEP entre las mujeres. Sin embargo, las mujeres Black/AA no tenían menos probabilidades de acudir a un profesional sanitario en el último año. Los datos sugieren que el hecho de que los proveedores no hablen ni aborden el riesgo de VIH con las PWID de raza Black/AA es un obstáculo importante para acceder a una atención y prevención eficaces.